tradingkey.logo

Progyny Inc

PGNY
查看詳細走勢圖
26.960USD
+0.330+1.24%
收盤 12/22, 16:00美東報價延遲15分鐘
2.32B總市值
41.31本益比TTM

Progyny Inc

26.960
+0.330+1.24%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.24%

5天

+2.35%

1月

+4.25%

6月

+28.50%

今年開始到現在

+56.29%

1年

+88.01%

查看詳細走勢圖

TradingKey Progyny Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Progyny Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名8/78位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價29.10。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Progyny Inc評分

相關信息

行業排名
8 / 78
全市場排名
63 / 4582
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 11 分析師
買入
評級
29.100
目標均價
+17.81%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Progyny Inc亮點

亮點風險
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
業績高增長
公司營業收入穩步增長,連續3年增長48.33%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入1.17B美元
估值合理
公司最新PE估值40.80,處於3年歷史合理位
機構減倉
最新機構持股88.02M股,環比減少24.51%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉1.50K股

Progyny Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Progyny Inc簡介

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
公司代碼PGNY
公司Progyny Inc
CEOAnevski (Peter)
網址https://www.progyny.com/

常見問題

Progyny Inc(PGNY)的當前股價是多少?

Progyny Inc(PGNY)的當前股價是 26.960。

Progyny Inc 的股票代碼是什麼?

Progyny Inc的股票代碼是PGNY。

Progyny Inc股票的52週最高點是多少?

Progyny Inc股票的52週最高點是27.510。

Progyny Inc股票的52週最低點是多少?

Progyny Inc股票的52週最低點是13.960。

Progyny Inc的市值是多少?

Progyny Inc的市值是2.32B。

Progyny Inc的淨利潤是多少?

Progyny Inc的淨利潤為54.34M。

現在Progyny Inc(PGNY)的股票是買入、持有還是賣出?

根據分析師評級,Progyny Inc(PGNY)的總體評級為買入,目標價格為29.100。

Progyny Inc(PGNY)股票的每股收益(EPS TTM)是多少

Progyny Inc(PGNY)股票的每股收益(EPS TTM)是0.653。
KeyAI